Catalyst Wire Dossier Catalyst Wire Dossier

Expanded CELL ENdocardiac Transplantation (EXCELLENT) therapy

· CellProthera
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Expanded CELL ENdocardiac Transplantation (EXCELLENT) therapy, covering 2026-03-19 to 2026-03-19. Get the full timeline:

Most recent: Clinical Trial Update: EXCELLENT (EXpanded CELL ENdocardiac Transplantation) [Phase 2]

See pricing